Secondary metabolites have been shown to exhibit a wide range of biological activities, including anticancer properties. These compounds can interfere with various stages of cancer development, including initiation, promotion, and progression. They can induce apoptosis (programmed cell death), inhibit angiogenesis (formation of new blood vessels), and modulate the immune response.
